Polymorphic forms of troglitazone having enhanced anti-diabetic

Details Polymorphic forms of troglitazone having enhanced anti-diabetic Polymorphic forms of troglitazone having enhanced anti-diabetic

1996-06-19

1997-12-23

Krass, Frederick

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514370, 548183, 548184, 548191, C07D41712, A61K 31425

Patent

active

057008205

ABSTRACT:
Novel polymorphic forms of Troglitazone and methods for preparing the polymorphic forms of Troglitazone. The polymorphic forms of Troglitazone can be used to treat diabetic ailments.

REFERENCES:
patent: 4316849 (1982-02-01), Bonaldi et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 5248699 (1993-09-01), Sysko et al.
patent: 5319097 (1994-06-01), Holohan et al.
Horikoshi, H. et al. Annul. Rep. Sankyo Res. Lab. 46, 1-57 (1994).

Affiliated with

Also associated with

Rating

Polymorphic forms of troglitazone having enhanced anti-diabetic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polymorphic forms of troglitazone having enhanced anti-diabetic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphic forms of troglitazone having enhanced anti-diabetic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1803068